A new study published in the Nature Medicine monthly journal highlights the benefits and risks of weight-loss drugs like Ozempic and Wegovy. Positives include reduced risks of infections and cardiac arrest, but could put people at risk for gastrointestinal issues and inflammation of kidneys. Experts warn more research on a larger sample is still needed.
